Introduction
HIV-1 enters a cell by attaching to CD4 on the cell surface before interacting with its principal coreceptor CCR-5 or CXCR-4 which triggers fusion of viral and cellular membranes. 1, 2 Based upon HIV-1 phenotypes, HIV-1 strains can be classified as M-tropic, T-tropic or dual-tropic. [3] [4] [5] CCR-5 is a principal coreceptor for M-tropic HIV-1 fusion and entry into lymphocytes and monocytes/macrophages. [6] [7] [8] [9] [10] [11] CXCR-4 is a principal coreceptor for T-tropic HIV-1.
12 M-tropic viruses represent the prevalent phenotype isolated in individuals shortly after HIV-1 infection and during the asymptomatic periods of the diseases. [3] [4] [5] T-tropic viruses, predominantly found in the late course of HIV-1 infection, induce the formation of syncytia in CD4 + cell lines, infect PBLs faster, and replicate in these cells at a higher rate than Mtropic isolates. [3] [4] [5] Occurrence of T-tropic HIV isolates is associated with CD4
+ cell decline and progression to AIDS. Dual-tropic viruses replicate well both in T cell lines and primary macrophages, and may represent an important transitional phenotype. [3] [4] [5] Several recent studies have demonstrated that individuals with a homozygous genetic defect in CCR-5 are highly resistant to HIV-1 infection, and are not associated with clinical conditions, [13] [14] [15] [16] suggesting that inactivation of the HIV-1 coreceptors may have therapeutic appli-
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17
The CC-chemokine, regulated-upon-activation, normal T expressed and secreted (RANTES), a ligand for CCR -5, 18 was targeted to the ER lumen and found to prevent effectively the transport of newly synthesized CCR-5 to the cell surface. The lymphocytes expressing the CCintrakine (RANTES-K) were resistant to M-tropic HIV-1 infection, while retaining normal cell functions. In an accompanied study, stromal cell-derived factor (SDF)-1␣, a ligand for CXCR-4, 19, 20 was also targeted to the ER to inactivate CXCR-4, and the viable lymphocytes expressing CXC-intrakine (SDF-K) were found to resist T-tropic HIV-1 infection. 21 These results indicate the therapeutic application of this genetic intrakine strategy to control HIV-1 infection. However, T-tropic and M-tropic HIV-1 viruses can co-exist in the same HIV-infected individual, while some species of HIV-1 viruses are dual-tropic. [22] [23] [24] In addition, HIV-1 viruses are likely to be adaptable in the use of these coreceptors. [3] [4] [5] [22] [23] [24] Given these concerns, inactivation of either CCR-5 or CXCR-4 alone may not be sufficient to block virus infection in HIV-1-infected individuals and to prevent disease progression. Apparently, co-inactivation of both the principal M-tropic and Ttropic coreceptors would be a superior approach to control HIV-1 infection. In this study, we demonstrate that genetic co-inactivation of both the M-and T-tropic coreceptors can be accomplished by coexpression of the CC-and CXC-intrakines.
Results

Co-expression of CC-and CXC-intrakines
The expression vectors for CC-intrakine (RANTES-K) or CXC-intrakine (SDF-K) were constructed as described previously.
17, 21 A bicistronic vector (pCMV-S-K/R-K) with an internal ribosome entry site (IRES) sequence 25 was constructed for co-expression of CC-and CXCintrakines (Figure 1a) . By using this vector with IRES, a single mRNA is transcribed under the control of an upstream promoter, and two gene products are translated independently from a single mRNA. The translation of the first intrakine gene is cap-dependent, and the second intrakine is translated under control of IRES in a cap-independent manner. The bicistronic expression cassette was further cloned into a retroviral shuttle vector with the truncated nerve growth factor receptor (⌬NGFR) gene. 21 To examine co-expression of the CC-and CXC-intrakines by the bicistronic vector, HeLa cells were transfected with various expression vector DNAs, and 48 h later radiolabeled with 35 S-Trans for 6 h. The cell lysates and culture media were then immunoprecipitated with either an anti-RANTES or anti-SDF-1 antibody. As shown in Figure 1b , a protein band, corresponding to RANTES-K, was found in the lysates of the pCMV-S-K/R-K-transfected cells when immunoprecipitated with the anti-RANTES antibody, while the protein band of SDF-K was also found in the lysates of the pCMV-S-K/R-K-transfected cells when immunoprecipitated with the anti-SDF-1 antibody. No corresponding protein band was detected in the control cell lysates. The RANTES-K and SDF-K intrakines were predominately found in cell lysates, not in the culture medium, in agreement with our previous observations. 17, 21 Thus, the CC-and CXC-intrakines were co-expressed by the bicistronic vector and retained intracellularly.
Figure 1 (a) Schematic representation of construction of expression vectors. The expression vectors pCMV-R-K, LNCX-R-K, pCMV-S-K and LNCX-S-
Blockade of HIV-1 entry into transduced lymphocyte lines We initially used a transient assay to evaluate the effect of pCMV-S-K/R-K on the cell surface CCR-5 or CXCR-986 4-mediated syncytium formation. 17 Cotransfection of the bicistronic expression vector (pCMV-S-K/R-K) was shown significantly to inhibit both M-tropic envelope (ADAenv or YU2env)-and T-tropic envelope (IIIB)-mediated syncytium formation, while cotransfection of the expression vector pCMV-R-K or pCMV-S-K only inhibited either the M-tropic or T-tropic envelopemediated syncytium formation, respectively (data not shown). To examine further the effects of CC-and CXCintrakine co-expression, a CCR-5/CXCR-4/CD4-positive human lymphocyte line, PM-1, 7, 26 was transfected with the bicistronic expression vector pCMV-S-K/R-K. The transduced lymphocytes (PM-S-K/R-K) were generated after G418 selection. The R-K and S-K gene incorporation into the transduced lymphocytes was demonstrated by genomic PCR amplifications (data not shown). PM-control and PM-S-K/R-K cells were shown to have similar cell viability, determined by trypan blue exclusion, and comparable proliferation curves (data not shown). To examine directly the effects of intrakines on the CCR-5 and CXCR-4 surface expression, a flow cytometric assay was used. The surface expression of CCR-5 and CXCR-4 was detected on the control PM-CMV cells, but decreased to background levels on PM-S-K/R-K. In contrast, comparable levels of the surface expression of CD3 and CD4 were detected on both PM-CMV and PM-S-K/R-K (data not shown). The blockade of surface expression of CCR-5 and CXCR-4 on the primary human lymphocytes was also observed (see below).
We then examined whether co-expression of RANTES-K and SDF1-K renders the transduced lymphocytes resistant to the entry of M-and T-tropic HIV-1 by using an envelope-complementation assay. 11, 17 In the complementation assay, HIV-1 envelope glycoproteins expressed in trans complement a single round of replication of an envelope-deleted provirus encoding the chloramphenicol acetyltransferase (CAT) gene. 11 As shown in Figure 2a , when infected with the recombinant M-tropic YU2 or ADA viruses, high levels of CAT activity were detected in PM-control, but only background levels of CAT activity were detected in PM-S-K/R-K. Similarly, when infected with the recombinant Ttropic IIIB virus, high levels of CAT activities were detected in PM-control, but only background levels of CAT activity were detected in PM-S-K/R-K. However, in the PM-S-K cultures infected with the recombinant Mtropic viruses, high levels of CAT activity were detected, indicating that PM-S-K is still susceptible to M-tropic HIV-1 infection. High levels of CAT activity were also detected in the PM-R-K culture when infected with the recombinant T-tropic virus. Thus, these results indicate that co-expression of CC-and CXC-intrakines blocked both M-and T-tropic HIV-1 entry into the transduced lymphocytes.
To determine the anti-HIV-1 activity of the coexpression of CC-and CXC-intrakines, the transduced and control lymphocytes were equally infected with an M-tropic virus (JRFL), or T-tropic virus (IIIB). In the PMcontrol cultures infected with either M-or T-tropic viruses, high levels of reverse transcriptase (RT) activity or p24 were detected 6 days after infection (Figure 2b ). In contrast, in the PM-S-K/R-K cultures, only low levels of RT activity or p24 were detected during the period observed when infected with either M-tropic or T-tropic HIV-1 viruses. To determine the broad anti-HIV-1 activity further, a dual tropic HIV-1 virus (89.6), which was shown to be capable of utilizing CCR-5 and CXCR-4, 9 was used to infect PM-S-K/R-K. High levels of p24 were detected in the infected PM-control, but only low levels of p24 were detected in the infected PM-S-K/R-K (Figure 2b ). Taken together, these results indicate that the transduced lymphocytes co-expressing CC and CXCintrakines were broadly resistant to the infection of Mtropic, T-tropic and dual-tropic HIV-1 viruses.
Broad anti-HIV-1 effects in primary PBLs
In order to examine in vivo potential, the anti-HIV-1 activities of CC-and CXC-intrakines were examined in human peripheral blood lymphocytes (PBLs). The recombinant retroviral shuttle vector (LNCX-S-K/R-K) with ⌬NGFR which is expressed on transduced cells as a marker for quantifying the gene transfer efficiency and isolating transduced PBLs 21 ( Figure 1a ) were used to generate recombinant retroviral vectors. The recombinant retroviral vectors were produced from transiently transfected packaging cells (Bing), 21, 27, 28 and used to transduce stimulated PBLs. About 10% of the stimulated PBLs were transduced by the recombinant retroviral vector (LNCX-S-K/R-K) or control retroviral vector (MN) that expresses the ⌬NGFR marker only. 29 The transduced PBLs were then isolated with an anti-NGFR/anti-IgG-magnetic bead method. 21 After isolation, over 92% of the PBL population were positive for the NGFR marker (Figure 3a) .
To assess whether the surface expression of CCR-5 and CXCR-4 was selectively blocked by the CC-and CXCintrakines, the PBLs transduced with LNCX-S-K/R-K or MN were isolated and subjected to flow cytometric analysis. As shown in Figure 3b , there were comparable levels of the surface expression of CD3, CD4 and CCR2 molecules on the PBLs transduced with either LNCX-S-K/R-K or MN. In contrast, the surface expression of both CXCR-4 and CCR-5 on the PBLs transduced with LNCX-S-K/R-K was dramatically decreased, when compared with the surface expression of these molecules on the PBLs transduced with MN.
To determine the selective co-inactivation of CCR-5 and CXCR-4 in the transduced PBLs further, a sensitive chemotaxis assay was used to determine the responsiveness of the transduced PBLs to the stimulation of several recombinant chemokines. 30 As shown in Figure 3c , the responsiveness of PBLs transduced with LNCX-S-K/R-K with the stimulation of recombinant SDF-1 was significantly decreased, when compared with that of PBLs transduced with the control MN. Similarly, PBLs transduced with LNCX-S-K/R-K also failed to respond to RANTES stimulation. Taken together, these results indicate that the co-expression of the CC-and CXC-intrakines inactivated both the principal M-tropic and T-tropic coreceptors CCR-5 and CXCR-4 in primary lymphocytes.
To evaluate the anti-HIV-1 effect of co-expression of CC-and CXC-intrakines in PBLs, the isolated PBLs transduced with either LNCX-S-K/R-K or MN were infected with M-tropic (ADA and JRFL), T-tropic (IIIB) and dualtropic (89.6) viruses, respectively, and the viral production in the cultures was examined by measuring viral p24 level. As shown in Figure 4 , only low levels of p24 were detected in the cultures of LNCX-S-K/R-K-transduced PBLs infected with either the M-tropic or T-tropic HIV-1 strains, but high levels of p24 were detected in the MN (control)-transduced PBL culture infected with these HIV-1 viruses. Significantly, the infection of the dualtropic 89.6 strain was also effectively blocked in the PBLs transduced with LNCX-S-K/R-K. Thus, the co-expression of CC-and CXC-intrakines broadly protects primary human PBLs from T-tropic, M-tropic and dual-tropic virus infection.
Responsiveness to antigen and mitogen stimulation
After demonstrating the anti-HIV-1 activity, we tried to determine whether the co-inactivation of CCR-5 and CXCR-4 has adverse effects on primary lymphocytes. PBLs transduced with LNCX-S-K/R-K were found to have comparable viability with the PBLs transduced with the MN control. Cell proliferation and DNA synthesis rates of the PBLs transduced with LNCX-S-K/R-K were also comparable with that of the control PBLs transduced with MN in the stimulation condition with the anti-CD3/CD28 or PHA (data not shown). We also assessed whether the transduced PBLs retain the responsiveness to recall antigen stimulation. Since almost every single individual was immunized with the tetanus antigens, 31 PBLs derived from normal adults were transduced, and then stimulated with tetanus antigens. After the tetanus antigen stimulation, the memory immune response to the antigen stimulation was determined by measuring IL-2 production and DNA synthesis rate of the PBLs. As shown in Figure 5 , IL-2 production of PBLs transduced with LNCX-S-K/R-K was dramatically increased to levels comparable with that of the control PBLs transduced with MN, after tetanus antigen stimulation. Similarly, after tetanus antigen stimulation 3 H-thymidine incorporation of the PBLs transduced with LNCX-S-K/R-K was also dramatically increased, to levels comparable with that of the control PBLs, indicating the transduced PBLs actively proliferated after the antigen stimulation. Thus, these results, together with the results from the flow cytometric assay and chemotaxis assay (Figure 3b and c) , indicate that co-expression of CC-and CXC-intrakines effectively inactivates both CCR-5 and CXCR-4, but does not interfere with normal lymphocyte functions.
Discussion
In this study, we utilized a novel 'intrakine' strategy to genetically co-inactivate both the M-tropic and T-tropic HIV-1 principal coreceptors CCR-5 and CXCR-4 in lymphocytes. The lymphocytes with the phenotypic knockout of these coreceptors were demonstrated to resist broadly the infection of M-tropic, T-tropic and dualtropic HIV-1 viruses. Moreover, the co-inactivation of the chemokine coreceptors does not appear to have adverse effects on human T cell biological features. Thus, this study indicates that the genetic co-inactivation of the Mand T-tropic coreceptors in HIV-1 susceptible cells could be developed into an effective approach for the treatment of HIV-1 infection and AIDS.
The progression to AIDS after HIV-1 infection is associated with a phenotypic shift from an M-tropic to a Ttropic virus. [3] [4] [5] The ability of HIV-1 strains to utilize different coreceptors seems to be a critical determinant of disease progression, although the selective forces driving this phenotypic transition are not yet defined. Given the HIV-1 adaptability to use these coreceptors, the selective pressure on HIV-1 by inactivating CCR-5 might result in gaining the use of the T-tropic coreceptor CXCR-4, which
Figure 3 Co-inactivation of CCR-5 and CXCR-4 on transduced primary PBLs. Fresh human PBLs were transduced with recombinant retroviral vectors LNCX-S-K/R-K or MN, and the transduced PBLs were isolated with the anti-NGFR/magnetic bead method. (a) Transduction of intrakine genes. The transduced PBLs and normal PBLs were incubated with an anti-NGFR antibody, followed by incubation with an anti-mouse IgG-FITC (Sigma) and then analyzed on a Becton Dickinson FACScan. Over 92% of PBLs transduced with LNCX-S-K/R-K or MN were positive for the NFGR marker. a, untransduced PBLs, b, S-K/R-K-transduced PBLs and c, MN-transduced PBLs. (b) Phenotypic knock-out of CCR-5 and CXCR-4 on the transduced PBLs by flow cytometric assay. PBLs transduced with LNCX-S-K/R-K or MN control vector were isolated and incubated with monoclonal antibodies against CXCR-4,
42 CCR-5 43 may accelerate disease progression. In addition, T-tropic and M-tropic HIV-1 viruses can co-exist in the same HIVinfected individual, [3] [4] [5] 22, 23 and some viruses are dualtropic viruses, using CCR-5 and CXCR-4 to infect T cells and macrophages. 22, 23, 32, 33 Moreover, some viruses could even by-pass the utilization of CCR-5, as documented in individuals with a homozygous CCR-5 genetic defect who were infected with HIV-1. 33, 34 Thus, it is conceivable that inactivation of either M-tropic or T-tropic coreceptors alone may not be sufficient to prevent HIV-1 infection and disease progression. In this study, the coinactivation of both the M-tropic and T-tropic HIV-1 coreceptors by the CC-and CXC-intrakines results in broad blockade of M-and T-tropic HIV-1 infection. This approach to co-inactivate both the M-tropic and T-tropic HIV-1 coreceptors, therefore, should have superior anti-HIV-1 activity over the inactivation of an M-tropic or Ttropic coreceptor alone. With the feature of this novel intrakine strategy uniquely targeted at the conserved cellular receptors to prevent HIV-1 entry, 17,21 this intrakine approach for co-inactivation of both the M-tropic and T-tropic principal coreceptors should effectively protect the transduced cells from HIV-1 infection.
A concern about the broad inactivation of chemokine receptors is whether the transduced lymphocytes would retain normal biological functions. Several lines of evidence from this study suggest that the co-inactivation of CCR-5 and CXCR-4 by intrakines apparently does not have adverse effects on primary lymphocytes. First, the transduced lymphocytes retained normal cell proliferation rates and viability in the stimulation conditions. Second, the cell surface markers, such as CD3, CD4 and CCR2, of the transduced lymphocytes remained normal. Third, the transduced lymphocytes normally responded to recall antigen stimulation as well as mitogen stimulation in IL-2 production and cell proliferation. Moreover, the transduced lymphocytes also normally responded to stimulation of the chemokines, such as MCP-1, which can use chemokine receptor CCR2 (data not shown). Due to the redundancy of the chemokine family, functions of the inactivated chemokine receptors may be compensated by other chemokine receptors. Thus, this study, to our knowledge, is the first to demonstrate that co-inactivation of the M-and T-tropic principal coreceptors CCR-5 and CXCR-4 in lymphocytes or other cells is a viable strategy for the blockade of HIV-1 infection.
Several additional chemokine receptors or related molecules, such as, STRL33/Bonzo, BOB/GPR15 and US28 encoded by human cytomegalovirus, were recently identified as functioning as HIV-1 coreceptors, although the biological significance of these receptors for HIV-1 entry and pathogenesis in humans is not yet established. [35] [36] [37] [38] However, accumulated evidence indicates that CCR-5 and CXCR-4 are the principal coreceptors for HIV-1. [7] [8] [9] [10] [11] [14] [15] [16] 19, 20 Co-inactivation of these coreceptors should block infection of the majority of HIV-1 strains in an infected individual, regardless of viral phenotypes or stages of HIV-1 infection, even if failing to block a fraction of HIV-1 strains utilizing other minor coreceptors. In summary, this genetic approach to co-inactivate both the principal M-tropic and T-tropic HIV-1 coreceptors in lymphocytes or stem cells, together with chemotherapy, should provide a promising therapeutic strategy toward the goal of long-term control of HIV-1 infection. 
Materials and methods
Construction of expression vectors
The native RANTES and SDF-1 genes and their derivatives were cloned into expression vectors, as described previously 17,21 ( Figure 1a) . The vector LNCX-S-K was constructed as follows: the retroviral vector pLNCX was cut with BclI/SphI and the vector DNA fragment without the Neo sequence was gel-purified. The plasmid MN containing a truncated version of the low-affinity nerve growth factor (⌬NGFR) was generously provided by Dr C Smith (Duke University, Durham, NC, USA). ⌬NGFR DNA fragments were PCR-amplified from the plasmid MN, and incompletely cut with BclI/SphI, and ligated into the pLNCX. The bicistronic expression vector pCMV-S-K/R-K was constructed as follows: the SDF-1␣-SEKDEL DNA fragments were PCR-amplified and cut with HindIII/NotI. The RANTES-KDEL DNA fragment was PCR-amplified, cut with NheI/XbaI, and cloned into the pCMV-Fab105-PE40 which contains the IRES sequence. 25, 39 The resultant pCMV-Fd105-IRES/R-K construct was cut with NotI/XbaI and the IRES-RANTES-SEKDEL DNA fragment was gel-purified. The HindIII/NotI-cut SDF-1␣-SEKDEL fragment and the NotI/XbaI-cut IRES-RANTES-KDEL DNA fragment were then cloned into pRc/CMV by three-piece ligation. The bicistronic retroviral shuttle vector LNCX-S-K/R-K was further constructed by cloning the SDF-1␣-KDEL/IRES/RANTES-K DNA fragment into the LNCX/⌬NGFR vector. The resultant constructs were identified by restriction enzyme digestions and further confirmed by DNA sequencing (DNA sequencing core facility of Wake Forest University).
Detection of protein expression and flow cytometric assay To label and immunoprecipitate recombinant proteins, cells were radiolabeled with 35 S-cysteine or 35 S-Trans and precipitated with antibodies. 40 The protein samples were analyzed by electrophoresis on SDS-polyacrylamide gels and visualized by a phosphorimager.
17, 21 For flow cytometric assay, 5 × 10 5 cells were incubated with a primary antibody for 1 h, followed by incubation with a fluorescein-conjugate. 17 The cells were then analyzed on a Becton Dickinson FACScan (Mountain View, CA, USA).
Envelope-complementation assay 293 Cells grown on 10 cm dishes were cotransfected with pHXB⌬envCAT (20 g) and an envelope protein expressor (5 g).
12,17 Forty-eight hours later, the culture medium was harvested, and RT activities in the supernatant were measured. 21 The recombinant viruses (20 000 c.p.m. RT activities) were used to infect target cells by overnight incubation, and 60 h later, the target cells were lysed and used for determination of CAT activity using a Promega kit (Madison, WI, USA).
Retroviral vector production, gene transduction and isolation of transduced PBLs PBMC from healthy individuals were separated on a Ficoll-Hypaque density gradient, and nonadherent PBLs were stimulated in culture medium (RPMI-1640/20% FCS supplemented with rIL-2 (500 IU/ml) (Chiron, CA, USA) and anti-CD3 (5 ng/ml) (PharMingen, San Diego, CA, USA)) for 48 h. An amphotropic retroviral packaging
